Search by Drug Name or NDC
NDC 61919-0865-90 PHENTERMINE HCL C-IV 30 mg/1 Details
PHENTERMINE HCL C-IV 30 mg/1
PHENTERMINE HCL C-IV is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Direct_Rx. The primary component is PHENTERMINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Phentermine is used for a limited period of time to speed weight loss in overweight people who are exercising and eating a low-calorie diet. Phentermine is in a class of medications called anorectics. It works by decreasing appetite.
Related Packages: 61919-0865-90Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Phentermine
Product Information
| NDC | 61919-0865 |
|---|---|
| Product ID | 61919-865_f9261f0d-fcef-339c-e053-6394a90a6f51 |
| Associated GPIs | 61200070100115 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | PHENTERMINE HCL C-IV |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | PHENTERMINE HCL C-IV |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | PHENTERMINE HYDROCHLORIDE |
| Labeler Name | Direct_Rx |
| Pharmaceutical Class | Appetite Suppression [PE], Increased Sympathetic Activity [PE], Sympathomimetic Amine Anorectic [EPC] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA091359 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 61919-0865-90 (61919086590)
| NDC Package Code | 61919-865-90 |
|---|---|
| Billing NDC | 61919086590 |
| Package | 90 CAPSULE in 1 BOTTLE (61919-865-90) |
| Marketing Start Date | 2019-06-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |